Development of a cancer-targeted tissue-specific promoter system.


Present cancer gene therapy using proapoptotic genes has had limited success because the therapy is prone to cause side effects as a result of the lack of tissue and cancer specificity. To target cancer cells without damaging normal cells, we have designed a novel dual promoter system in which a tissue-specific transcription system under the control of a… (More)

6 Figures and Tables


  • Presentations referencing similar topics